is semaglutide a sglt2 inhibitor Multiple Sites for the Beneficial Effects of Inhibition SGLT2 Inhibitors and Adverse Events:

Packer M et al (2020): Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial

Theres a new safety signal (dysesthesia, an abnormal skin sensation) that wasnt seen in earlier trials

This man-made peptide, which has the CAS number 910463-68-2, has sparked a lot of interest in drug studies and clinical uses linked to metabolic diseases

Bruising

So if you are feeling a sense of urgency or firmly want to get started, the risk of delaying other effective treatments (see below) until the duration of the study is completed may not be worth it